As of 2024-12-14, the Fair Value of Denali Therapeutics Inc (DNLI) is -14.85 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 23.47 USD, the upside of Denali Therapeutics Inc is -163.28%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -197.60 | 71.10 | -290.60 | -326.00 | -145.22 | -177.66 |
| YoY growth | -445.86% | 135.98% | -508.72% | -12.18% | 55.45% | -155.06% |
| Market Cap (mil) | 3,377.80 |
| P/E | |
| Forward P/E |
| EPS | -2.97 |
| Avg earnings growth rate | -155.06% |
| TTM earnings | -427.49 |